At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Aug 10, 2001·Updated Feb 18, 2016
In Brief
An observational study for Cardiovascular Diseases and 5 related conditions. Completed.
Detailed Summary
To examine the independent association of serum total homocysteine and C-reactive protein with arteriosclerotic cardiovascular disease morbidity and mortality.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Atherosclerosis, Heart Diseases, Diabetes Mellitus, Non-insulin Dependent, Hypertension, Diabetes Mellitus
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2001
First PostedAug 2001
Study CompletionJun 2004
TodayJul 2026
First PostedAug 10, 2001
Enrollment StartApr 1, 2001
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 24.9 years ago